Contribution of RIPK1 kinase activity to cell death induced by anti-cancer agents using 7-CI-O-Nec-1, a potent and highly selective RIPK1 kinase inhibitor

被引：0

作者：

Alavi, Alireza

Benetatos, Christopher

Yuan, Junying

Degterev, Alexei

Franklin, Jessica

Condon, Stephen

McKinlay, Mark

Chunduru, Srinivas

机构：

[1] TetraLog Pharmaceut Corp, Malvern, PA USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Tufts Univ, Sch Med, Boston, MA 02111 USA

来源：

CANCER RESEARCH | 2009年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2036

引用

页数：1

共 35 条

[1] Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
Zhang, Xixi
Zhang, Haiwei
Xu, Chengxian
Li, Xiaoming
Li, Ming
Wu, Xiaoxia
Pu, Wenjuan
Zhou, Bin
Wang, Haikun
Li, Dali
Ding, Qiurong
Ying, Hao
Wang, Hui
Zhang, Haibing
NATURE COMMUNICATIONS, 2019, 10 (1)
[2] Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
Xixi Zhang
Haiwei Zhang
Chengxian Xu
Xiaoming Li
Ming Li
Xiaoxia Wu
Wenjuan Pu
Bin Zhou
Haikun Wang
Dali Li
Qiurong Ding
Hao Ying
Hui Wang
Haibing Zhang
Nature Communications, 10
[3] Multitasking Kinase RIPK1 Regulates Cell Death and Inflammation
Newton, Kim
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2020, 12 (03):
[4] StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1
Dillon, Christopher P.
Balachandran, Siddharth
CYTOKINE, 2016, 78 : 47 - 50
[5] RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity
Contreras, Christopher J.
Mukherjee, Noyonika
Branco, Renato C. S.
Lin, Li
Hogan, Meghan F.
Cai, Erica P.
Oberst, Andrew A.
Kahn, Steven E.
Templin, Andrew T.
MOLECULAR METABOLISM, 2022, 65
[6] Structure-based development of potent and selective type-Ⅱ kinase inhibitors of RIPK1
Ying Qin
Dekang Li
Chunting Qi
Huaijiang Xiang
Huyan Meng
Jingli Liu
Shaoqing Zhou
Xinyu Gong
Ying Li
Guifang Xu
Rui Zu
Hang Xie
Yechun Xu
Gang Xu
Zheng Zhang
Shi Chen
Lifeng Pan
Ying Li
Li Tan
Acta Pharmaceutica Sinica B, 2024, 14 (01) : 319 - 334
[7] RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD
Van Eeckhoutte, Hannelore P.
Donovan, Chantal
Kim, Richard Y.
Conlon, Thomas M.
Ansari, Meshal
Khan, Haroon
Jayaraman, Ranjith
Hansbro, Nicole G.
Dondelinger, Yves
Delanghe, Tom
Beal, Allison M.
Geddes, Brad
Bertin, John
Vanden Berghe, Tom
De Volder, Joyceline
Maes, Tania
Vandenabeele, Peter
Vanaudenaerde, Bart M.
Deforce, Dieter
Skevin, Sonja
Van Nieuwerburgh, Filip
Verhamme, Fien M.
Joos, Guy F.
Idrees, Sobia
Schiller, Herbert B.
Yildirim, Ali Oender
Faiz, Alen
Bertrand', Mathieu J. M.
Brusselle, Guy G.
Hansbro, Philip M.
Bracke, Ken R.
EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (04)
[8] cIAPs control RIPK1 kinase activity-dependent and -independent cell death and tissue inflammation
Schorn, Fabian
Werthenbach, J. Paul
Hoffmann, Mattes
Daoud, Mila
Stachelscheid, Johanna
Schiffmann, Lars M.
Hildebrandt, Ximena
Lyu, Su Ir
Peltzer, Nieves
Quaas, Alexander
Vucic, Domagoj
Silke, John
Pasparakis, Manolis
Kashkar, Hamid
EMBO JOURNAL, 2023, 42 (22):
[9] Questioning the RIPK1 kinase activity involvement in acetaminophen-induced hepatotoxicity in mouse
Hameed, Huma
Farooq, Muhammad
Piquet-Pellorce, Claire
Hamon, Annaig
Samson, Michel
Le Seyec, Jacques
FREE RADICAL BIOLOGY AND MEDICINE, 2022, 178 : 243 - 245
[10] Structure guided design of potent and selective inhibitors for RIPK1 linked to necroptopic cell death
Ray, Soumya
Degterev, Alexei
Cuny, Gregory
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251

← 1 2 3 4 →